Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fear | 5 | 2015 | 271 | 1.410 |
Why?
|
| Extinction, Psychological | 4 | 2015 | 103 | 1.220 |
Why?
|
| Prefrontal Cortex | 3 | 2012 | 160 | 0.860 |
Why?
|
| Diterpenes | 1 | 2023 | 94 | 0.800 |
Why?
|
| Brain Ischemia | 1 | 2023 | 196 | 0.720 |
Why?
|
| Amygdala | 2 | 2012 | 125 | 0.680 |
Why?
|
| Behavior, Animal | 4 | 2014 | 369 | 0.540 |
Why?
|
| Parietal Lobe | 1 | 2015 | 10 | 0.460 |
Why?
|
| Conditioning, Classical | 1 | 2015 | 67 | 0.440 |
Why?
|
| Behavior | 1 | 2014 | 34 | 0.440 |
Why?
|
| Reward | 1 | 2014 | 106 | 0.410 |
Why?
|
| Brain Injuries | 1 | 2015 | 133 | 0.400 |
Why?
|
| Sensory Gating | 1 | 2012 | 5 | 0.400 |
Why?
|
| Decision Making | 1 | 2014 | 242 | 0.360 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2023 | 1737 | 0.340 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 35 | 0.340 |
Why?
|
| Rats | 8 | 2023 | 3701 | 0.330 |
Why?
|
| Conditioning, Operant | 1 | 2010 | 90 | 0.320 |
Why?
|
| Hippocampus | 1 | 2012 | 591 | 0.300 |
Why?
|
| Individuality | 1 | 2008 | 53 | 0.290 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 547 | 0.280 |
Why?
|
| Animals | 13 | 2023 | 16695 | 0.280 |
Why?
|
| Dentate Gyrus | 1 | 2008 | 42 | 0.280 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 78 | 0.270 |
Why?
|
| Long-Term Potentiation | 1 | 2008 | 109 | 0.270 |
Why?
|
| Mental Recall | 1 | 2006 | 81 | 0.250 |
Why?
|
| Electroshock | 3 | 2015 | 15 | 0.230 |
Why?
|
| Motor Activity | 2 | 2016 | 438 | 0.200 |
Why?
|
| Aging | 1 | 2008 | 764 | 0.190 |
Why?
|
| Male | 11 | 2023 | 22779 | 0.190 |
Why?
|
| Maze Learning | 3 | 2007 | 112 | 0.180 |
Why?
|
| Piperazines | 3 | 2007 | 117 | 0.170 |
Why?
|
| Neural Pathways | 2 | 2012 | 139 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2012 | 574 | 0.140 |
Why?
|
| Phosphodiesterase Inhibitors | 3 | 2007 | 35 | 0.130 |
Why?
|
| Amphetamine | 1 | 2016 | 21 | 0.130 |
Why?
|
| Unconsciousness | 1 | 2016 | 4 | 0.130 |
Why?
|
| Propofol | 1 | 2016 | 8 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 27 | 0.130 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2007 | 36 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 27 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 35 | 0.130 |
Why?
|
| Nitric Oxide Synthase | 2 | 2007 | 134 | 0.120 |
Why?
|
| Brain Mapping | 1 | 2016 | 132 | 0.120 |
Why?
|
| Memory | 1 | 2016 | 175 | 0.120 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2015 | 13 | 0.120 |
Why?
|
| Action Potentials | 2 | 2016 | 246 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 181 | 0.110 |
Why?
|
| Rats, Inbred F344 | 4 | 2008 | 256 | 0.110 |
Why?
|
| Punishment | 1 | 2014 | 7 | 0.110 |
Why?
|
| Primates | 1 | 2014 | 38 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 457 | 0.110 |
Why?
|
| Muscimol | 1 | 2012 | 16 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 113 | 0.100 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 74 | 0.100 |
Why?
|
| Time Factors | 2 | 2008 | 1848 | 0.100 |
Why?
|
| Sulfones | 3 | 2007 | 47 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1058 | 0.080 |
Why?
|
| Female | 2 | 2023 | 24018 | 0.080 |
Why?
|
| Anxiety | 1 | 2016 | 847 | 0.080 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 80 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2008 | 135 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2008 | 138 | 0.070 |
Why?
|
| Nootropic Agents | 1 | 2007 | 7 | 0.070 |
Why?
|
| Tetrodotoxin | 1 | 2006 | 23 | 0.060 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 20 | 0.060 |
Why?
|
| Neurons | 1 | 2012 | 1246 | 0.060 |
Why?
|
| Muscarinic Antagonists | 1 | 2004 | 11 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2004 | 17 | 0.060 |
Why?
|
| Mice | 1 | 2015 | 6490 | 0.050 |
Why?
|
| Purines | 3 | 2007 | 40 | 0.050 |
Why?
|
| Brain | 1 | 2007 | 1452 | 0.040 |
Why?
|
| Adult | 1 | 2014 | 13458 | 0.030 |
Why?
|
| Humans | 2 | 2014 | 42163 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2016 | 27 | 0.030 |
Why?
|
| Cyclic GMP | 2 | 2007 | 55 | 0.030 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 2 | 2007 | 7 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2016 | 68 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2016 | 139 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2016 | 90 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2016 | 135 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2016 | 156 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2007 | 13 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2007 | 58 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2007 | 2111 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2007 | 381 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1112 | 0.010 |
Why?
|
| Cognition | 1 | 2007 | 458 | 0.010 |
Why?
|